1 |
王斌, 邢丹, 董圣杰, 等. 中国膝骨关节炎流行病学和疾病负担的系统评价 [J]. 中国循证医学杂志, 2018, 18(02): 134-142.
|
2 |
中华医学会骨科学分会关节外科学组, 中国医师协会骨科医师分会骨关节炎学组, 国家老年疾病临床医学研究中心(湘雅医院), 等. 中国骨关节炎诊疗指南(2021年版) [J]. 中华骨科杂志, 2021, 41(18): 1291-1314.
|
3 |
Martel-Pelletier J, Boileau C, Pelletier JP, et al. Cartilage in normal and osteoarthritis conditions [J]. Best Pract Res Clin Rheumatol, 2008, 22(2): 351-384.
|
4 |
Foster TE, Puskas BL, Mandelbaum BR, et al. Platelet-rich plasma: from basic science to clinical applications [J]. Am J Sports Med, 2009, 37(11): 2259-2272.
|
5 |
Randelli P, Arrigoni P, Ragone V, et al. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up [J]. J Shoulder Elbow Surg, 2011, 20(4): 518-528.
|
6 |
Whitney KE, Liebowitz A, Bolia IK, et al. Current perspectives on biological approaches for osteoarthritis [J]. Ann N Y Acad Sci, 2017, 1410(1): 26-43.
|
7 |
Zhao L, Kaye AD, Abd-Elsayed A. Stem cells for the treatment of knee osteoarthritis: a comprehensive review [J]. Pain Physician, 2018, 21(3): 229-242.
|
8 |
Braun HJ, Wasterlain AS, Dragoo JL. The use of PRP in ligament and meniscal healing [J]. Sports Med Arthrosc Rev, 2013, 21(4): 206-212.
|
9 |
Sánchez-González DJ, Méndez-Bolaina E, Trejo-Bahena NI. Platelet-rich plasma peptides: key for regeneration [J]. Int J Pept, 2012, 2012: 532519.
|
10 |
Kon E, Filardo G, Di Martino A, et al. Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use [J]. Knee Surg Sports Traumatol Arthrosc, 2011, 19(4): 516-527.
|
11 |
Deasy BM, Feduska JM, Payne TR, et al. Effect of VEGF on the regenerative capacity of muscle stem cells in dystrophic skeletal muscle [J]. Mol Ther, 2009, 17(10): 1788-1798.
|
12 |
Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? [J]. Implant Dent, 2001, 10(4): 225-228.
|
13 |
Marques LF, Stessuk T, Camargo IC, et al. Platelet-rich plasma (PRP): methodological aspects and clinical applications [J]. Platelets, 2015, 26(2): 101-113.
|
14 |
Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis [J]. Am J Sports Med, 2014, 42(1): 35-41.
|
15 |
Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis [J]. Nat Rev Rheumatol, 2013, 9(12): 721-730.
|
16 |
Saita Y, Kobayashi Y, Nishio H, et al. Predictors of effectiveness of platelet-rich plasma therapy for knee osteoarthritis: a retrospective cohort study [J]. J Clin Med, 2021, 10(19)
|
17 |
Joshi Jubert N, Rodríguez L, Reverté-Vinaixa MM, et al. Platelet-rich plasma injections for advanced knee osteoarthritis: a prospective, randomized, double-blinded clinical trial [J]. Orthop J Sports Med, 2017, 5(2): 2325967116689386.
|
18 |
Sun SF, Hsu CW, Lin HS, et al. A single intraarticular platelet-rich plasma improves pain and function for patients with early knee osteoarthritis: analyses by radiographic severity and age [J]. J Back Musculoskelet Rehabil, 2022, 35(1): 93-102.
|
19 |
Yurtbay A, Say F, Çinka H, et al. Multiple platelet-rich plasma injections are superior to single PRP injections or saline in osteoarthritis of the knee: the 2-year results of a randomized, double-blind, placebo-controlled clinical trial [J]. Arch Orthop Trauma Surg, 2022, 142(10): 2755-2768.
|
20 |
Le A, Enweze L, DeBaun MR, et al. Current clinical recommendations for use of platelet-rich plasma [J]. Curr Rev Musculoskelet Med, 2018, 11(4): 624-634.
|
21 |
Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee [J]. Curr Rev Musculoskelet Med, 2018, 11(4): 583-592.
|
22 |
Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma [J]. Am J Sports Med, 2011, 39(10): 2135-2140.
|
23 |
Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability [J]. J Bone Joint Surg Am, 2012, 94(4): 308-316.
|
24 |
Kikuchi N, Yoshioka T, Arai N, et al. A retrospective analysis of clinical outcome and predictive factors for responders with knee osteoarthritis to a single injection of leukocyte-poor platelet-rich plasma [J]. J Clin Med, 2021, 10(21)
|
25 |
Bec C, Rousset A, Brandin T, et al. A retrospective analysis of characteristic features of responders and impaired patients to a single injection of pure platelet-rich plasma in knee osteoarthritis [J]. J Clin Med, 2021, 10(8)
|
26 |
Mazzocca AD, McCarthy MB, Chowaniec DM, et al. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells [J]. Am J Sports Med, 2012, 40(8): 1742-1749.
|
27 |
Boswell SG, Schnabel LV, Mohammed HO, et al. Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons [J]. Am J Sports Med, 2014, 42(1): 42-49.
|
28 |
DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system [J]. Arthroscopy, 2012, 28(7): 998-1009.
|
29 |
Su CA, Jildeh TR, Vopat ML, et al. Current state of platelet-rich plasma and cell-based therapies for the treatment of osteoarthritis and tendon and ligament injuries [J]. J Bone Joint Surg Am, 2022, 104(15): 1406-1414.
|
30 |
Anitua E, Sánchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors [J]. Cell Prolif, 2009, 42(2): 162-170.
|
31 |
Subramanyam K, Alguvelly R, Mundargi A, et al. Single versus multi-dose intra-articular injection of platelet rich plasma in early stages of osteoarthritis of the knee: a single-blind, randomized, superiority trial [J]. Arch Rheumatol, 2021, 36(3): 326-334.
|
32 |
Hong M, Cheng C, Sun X, et al. Efficacy and safety of intra-articular platelet-rich plasma in osteoarthritis knee: a systematic review and meta-analysis [J]. Biomed Res Int, 2021, 2021: 2191926.
|
33 |
Braun HJ, Kim HJ, Chu CR, et al. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy [J]. Am J Sports Med, 2014, 42(5): 1204-1210.
|
34 |
殷文靖, 徐正良, 盛加根, 等. 去白细胞和富白细胞富血小板血浆对软骨细胞增殖迁移的作用[J/CD]. 中华关节外科杂志(电子版), 2016, 10(06): 618-623.
|
35 |
Riboh JC, Saltzman BM, Yanke AB, et al. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis [J]. Am J Sports Med, 2016, 44(3): 792-800.
|
36 |
Uchino S, Saita Y, Wada A, et al. The immature platelet fraction affects the efficacy of platelet rich plasma therapy for knee osteoarthritis [J]. Regen Ther, 2021, 18: 176-181.
|
37 |
Belk JW, Kraeutler MJ, Houck DA, et al. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials [J]. Am J Sports Med, 2021, 49(1):249-260.
|
38 |
Kim JH, Park YB, Ha CW. Are leukocyte-poor or multiple injections of platelet-rich plasma more effective than hyaluronic acid for knee osteoarthritis? A systematic review and meta-analysis of randomized controlled trials [J]. Arch Orthop Trauma Surg, 2022,
|
39 |
Zhang Q, Xu W, Wu K, et al. Intra-articular pure platelet-rich plasma combined with open-wedge high tibial osteotomy improves clinical outcomes and minimal joint space width compared with high tibial osteotomy alone in knee osteoarthritis: a prospective study [J]. Arthroscopy, 2022, 38(2): 476-485.
|
40 |
Dong C, Zhao C, Wang F. Clinical benefit of high tibial osteotomy combined with the intervention of platelet-rich plasma for severe knee osteoarthritis [J]. J Orthop Surg Res, 2022, 17(1): 405.
|
41 |
Kim CW, Seo SS, Lee CR, et al. Factors affecting articular cartilage repair after open-wedge high tibial osteotomy [J]. Knee, 2017, 24(5): 1099-1107.
|
42 |
Schuster P, Geßlein M, Schlumberger M, et al. Ten-year results of medial open-wedge high tibial osteotomy and chondral resurfacing in severe medial osteoarthritis and varus malalignment [J]. Am J Sports Med, 2018, 46(6): 1362-1370.
|
43 |
Mifune Y, Matsumoto T, Takayama K, et al. The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair [J]. Osteoarthritis Cartilage, 2013, 21(1): 175-185.
|
44 |
Schippinger G, Prüller F, Divjak M, et al. Autologous platelet-rich plasma preparations: influence of nonsteroidal anti-inflammatory drugs on platelet function [J]. Orthop J Sports Med, 2015, 3(6): 2325967115588896.
|
45 |
Kao DS, Zhang SW, Vap AR. A systematic review on the effect of common medications on platelet count and function: which medications should be stopped before getting a platelet-rich plasma injection? [J]. Orthop J Sports Med, 2022, 10(4): 23259671221088820.
|
46 |
Emory Healthcare. Platelet-rich-plasma therapy. (2021-3-8) [2022-12-9].
URL
|
47 |
Brophy RH, Fillingham YA. AAOS clinical practice guideline summary: management of osteoarthritis of the knee (nonarthroplasty), third edition [J]. J Am Acad Orthop Surg, 2022, 30(9): e721-721e729.
|
48 |
Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis [J]. Osteoarthritis Cartilage, 2019, 27(11): 1578-1589.
|
49 |
Chu J, Duan W, Yu Z, et al. Intra-articular injections of platelet-rich plasma decrease pain and improve functional outcomes than sham saline in patients with knee osteoarthritis [J]. Knee Surg Sports Traumatol Arthrosc, 2022, 30(12): 4063-4071.
|
50 |
Rai D, Singh J, Somashekharappa T, et al. Platelet-rich plasma as an effective biological therapy in early-stage knee osteoarthritis: One year follow up [J]. SICOT J, 2021, 7:6.
|
51 |
Moton RZ, Nawaz MZ, Latif M, et al. Clinical and functional outcomes following platelet rich plasma in the management of knee osteoarthritis: A case series in a tertiary care hospital [J]. J Pak Med Assoc, 2021, 71(Suppl 5) (8): S94-94S98.
|
52 |
Bennell KL, Paterson KL, Metcalf BR, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial [J]. JAMA, 2021, 326(20): 2021-2030.
|
53 |
Baria MR, Flanigan DC. Intra-articular platelet-rich plasma vs placebo injection and pain and medial tibial cartilage volume in patients with knee osteoarthritis [J]. JAMA, 2022, 327(12): 1184-1185.
|
54 |
Zhu Z, Ding C. Intra-articular platelet-rich plasma vs placebo injection and pain and medial tibial cartilage volume in patients with knee osteoarthritis [J]. JAMA, 2022, 327(12): 1186.
|
55 |
Lei Y, Cui D, Huang W. Intra-articular platelet-rich plasma vs placebo injection and pain and medial tibial cartilage volume in patients with knee osteoarthritis [J]. JAMA, 2022, 327(12): 1186-1187.
|
56 |
Mojica ES, Markus DH, Hurley ET, et al. Estimated time to maximum medical improvement of intra-articular injections in the treatment of knee osteoarthritis-a systematic review [J]. Arthroscopy, 2022, 38(3): 980-988.e4.
|
57 |
Costa L, Lenza M, Irrgang JJ, et al. How does platelet-rich plasma compare clinically to other therapies in the treatment of knee osteoarthritis? A systematic review and meta-analysis [J]. Am J Sports Med, 2022: 3635465211062243.
|
58 |
McLarnon M, Heron N. Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis [J]. BMC Musculoskelet Disord, 2021, 22(1): 550.
|
59 |
Kramer ME, Keaney TC. Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia [J]. J Cosmet Dermatol, 2018, 17(5): 666-671.
|
60 |
Zahir H, Dehghani B, Yuan X, et al. In vitro responses to platelet-rich-plasma are associated with variable clinical outcomes in patients with knee osteoarthritis [J]. Sci Rep, 2021, 11(1): 11493.
|
61 |
Cohen SA, Zhuang T, Xiao M, et al. Google trends analysis shows increasing public interest in platelet-rich plasma injections for hip and knee osteoarthritis [J]. J Arthroplasty, 2021, 36(10): 3616-3622.
|